Medical Marijuana Inc. Welcomes Blake Schroeder to Executive Team

by adminTorusBrand | Mar 29, 2016 | Company News, Kannaway

We’re extremely excited to introduce Blake Schroeder, who will be joining Medical Marijuana Inc. as Vice President of Operations and will serve as Chief Executive Officer of our portfolio company, Kannaway. Schroeder brings significant executive level experience in...

[HempMeds® Mexico] Our Visit to the American Academy for Anti-Aging Medicine Mexico’s Conference

by adminTorusBrand | Mar 16, 2016 | Company News, HempMeds Mexico

Our CEO Stuart Titus and representatives from our new division, HempMeds® Mexico, attended A4M Mexico’s recent conference, where Stuart was also a featured guest speaker. Watch the video below to get a look! Narration by Stuart Titus: “The A4M event in...

Medical Marijuana, Inc. Portfolio Investment Company, Kannalife Sciences, Inc. Notified of DEA Clearance for Import of High-Purity, Pharmaceutical-Grade Cannabidiol (CBD)

by adminTorusBrand | Mar 1, 2016 | Company News, Kannalife Sciences

U.S. Phyto-Medical Company Clears Regulatory Hurdle in Its Ongoing Feasibility Study With Catalent Pharma Solutions for the Development of a Novel Cannabinoid Therapeutic Agent to Treat HE and CTE SAN DIEGO, March 01, 2016 (GLOBE NEWSWIRE) — Medical Marijuana, Inc....

Kannalife Sciences, Inc.’s New Cannabis-Derived Compound KLS-13019 Covered by Reuters, Kannalife Explores IPO This Year

by adminTorusBrand | Feb 26, 2016 | Company News, Kannalife Sciences

Reuters Reports That Kannalife is Considering an Initial Public Offering This Year to Fund Development of a Cannabis-Based Treatment for a Brain Disorder That Affects 200,000 Americans SAN DIEGO, Feb. 26, 2016 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink:MJNA)...

AXIM Biotechnologies Lays Out Powerhouse IP Pipeline, Cannabinoid R&D in Interview

by adminTorusBrand | Feb 26, 2016 | Axim Biotechnologies, Company News, Press Releases

AXIM® Biotech Discusses Patented Cannabinoid-Release Chewing Gum – MedChew RX™; Future Patent-Pending Products Including: Oral Care, Skin Care, Suppository, and Ocular Treatments SAN DIEGO, Feb. 25, 2016 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink:MJNA) is...

Medical Marijuana, Inc. Portfolio Investment Company, Kannalife Sciences, Inc. Receives Publication through American Chemical Society for KLS-13019, a Novel Cannabidiol-Derived Target Drug Candidate for Hepatic Encephalopathy

by adminTorusBrand | Feb 22, 2016 | Company News, Kannalife Sciences, Press Releases

Kannalife Sciences, Inc., a Phyto-Medical Company™ has found through its research that KLS-13019 is 50x More Potent and Over 400-Fold Safer Than CBD SAN DIEGO, CA – February 18, 2016 – Medical Marijuana, Inc. (OTC Pink: MJNA) is pleased to announce that the Company’s...